Reticare USA | About Reticare
554
page-template,page-template-full_width,page-template-full_width-php,page,page-id-554,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive

About Reticare

Reticare is based on 15 years of research led by the Complutense University of Madrid (UCM) concerning risks of light from device screens on the retina. Backed by an extensive scientific knowledge, we develop products that prevent the consequential damages from technology usage.

About Reticare

Reticare is a young, contemporary company with a big mission: saving the world from a global vision crisis. Reticare is one of the worldwide main players and advisor for many governments and institutions on the topic of prevention from the risks of high energy light emitted from device screens.

Risks associated with using devices include symptoms such as headaches, eye strain and sleep disorders but, most importantly, irreversible damage to the retina proven by UCM’s studies. We are concerned about the serious risks associated with macular degeneration, the leading cause of central vision blindness in the world.

Today, more than 400,000 people, among them two Nobel Prize Winners, the U.S. Senate and the West Point Academy, use our solutions. Health organizations such as the Vision Council and specialties such as optometry, optics, ophthalmology and medicine already warn about the risks from device screens. Many recommend Reticare eye protectors to their patients.

Don’t take a chance, preserve your vision, the window to our world and our future.

Presentations

THE RETICARE LAUNCH

September 9, 2013 Reticare launched its first presentation at Ritz Carlton-Madrid, an historical day for world-wide technology. Together with Reticare, the University Complutense of Madrid (UCM), scientific researchers and ophthalmologists presented the latest in-vitro experiments that showed human retina cells died off massively when exposed to direct LED light. The consequences of such discovery can affect humanity, globally. However, when filters that absorb light frequencies are applied, the survival rate of cells increase exponentially. A large audience of people from various industries attended the launch, which received a wide coverage by the media.

RCC-HARVARD PRESENTATION

January 23, 2017 released its presentation at the Harvard Real Colegio Complutense (RCC) in Cambridge, Massachusetts (USA). Along with two Nobel Prize Winner advisors for Reticare, researchers and journalists, the results of the new experiments that were presented, further confirmed the results from the 2013 experiments with animals. The presentation analyzed and compared the results of exposing the retina of rats to tablet screens emitting white LED light with and without filters, proving that light causes cell death in the retina, and can lead to loss of vision.

The results from this presentation showed a quantitative analysis that after only three months of exposure, animals exposed to tablets experienced approximately a 23 percent increase in retina cell death. On the other hand, when Reticare filters were placed on screens of the tablets, there were no retina cell death. These results demonstrate that there is a world-wide issue which can be overcome with a simple solution like Reticare filters.

NEW EXPERIMENTS, UCM 2017

January 17, 2017 presentation of experiments at the center for the Distinguished Medical Association of Madrid. With more than 70 scientists, medical doctors, representatives from institutions of Spanish National Association for the Blind and from the Madrid local government, two concepts that were concluded was that the animal studies changed the way we conceived the effects of light from screens and the confirmation of high toxicity of screens effecting the retina. It was also demonstrated that children were at higher risk and received three times more light than adults, due to their physical anatomy, when using the same device.

HIGHLIGHTS

400,000 customers

1,500 people involved in studies

2 headquarters (USA and Spain)

2 Nobel Prize Winners as Scientific Advisors

Collaboration with the 3rd oldest University in the world

About the Complutense University of Madrid (UCM)

Established: 20 May 1293 (723 years old)

Top University in Spain – Ranked #1

Roster of alumni:

Nobel Prize Winners (7)

Principe de Asturias awards (18)

Miguel de Cervantes Prize (7)

European Commissioners

Presidents of the EU Parliament

European Council Secretary General

ECB Executive Board members

NATO Secretary General

UNESCO Director General

IMF Managing Director, and Heads of State


Celia Sanchez-Ramos, Lead Scientific Advisor

 

At Reticare, we are proud to have Dr. Sanchez-Ramos in our team as the leading scientist, researching the effect of light emitted from screens. Dr. Sanchez-Ramos holds a PhD in Preventive Medicine and Visual Sciences as well as Dr. Honoris Causa awarded by the International University Menendez Pelayo.

 

Nominee for the prestigious Príncipe de Asturias Awards, Dr. Sanchez-Ramos is one of the most important science researchers in Spain.


USE RETICARE TO PREVENT SERIOUS EYE HEALTH PROBLEMS